These multidisciplinary presentations provide information essential
to devising effective drug protocols in cardiovascular drug
development, facilitating the approval process. Guides researchers
and developers through the government drug approval process,
facilitating development, minimizing costs, and harmonizing
international standards employed in the creation of vital new
cardiovascular therapies! Cardiovascular Drug Developmentexplores
the delicate balance of efficacy and safety that cardiovascular
therapy must achieve to gain regulatory approval discusses the
search for surrogates and the need in some areas for natural
history endpoints reviews optimum strategies for protocol design in
the development of drugs to treat hypertension, cardiac
arrhythmias, heart failure, coronary artery disease, and
hypercholesterolemia and other lipid disorders compares and
contrasts the varying standards of evidence for drug approval in
the United States, Europe, and Asia and more! Cardiovascular Drug
Development will prove to be a valuable asset for cardiologists,
pharmacologists and pharmacists, regulatory affairs specialists,
and directors of research and development for pharmaceutical
|Country of origin:
||Fundamental and Clinical Cardiology
||Electronic book text
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!